Saturday, February 11, 2012

Posts tagged with the keyword: ‘Array BioPharma (NASDAQ:ARRY)’

FDA Pipeline Drug Updates: QLTI, LCT, BMTI, ARRY

FDA Pipeline Drug Updates: QLTI, LCT, BMTI, ARRY

The following report features FDA Clinical Trial Updates for: QLT Inc. (NASDAQ:QLTI), Living Cell Technologies (ASX:LCT), BioMimetic Therapeutics (NASDAQ:BMTI), Array BioPharma (NASDAQ:ARRY) QLTI: VISUDYNE (veteporfin), photodynamic or PDT light activated drug therapy, co-developed/marketed with Novartis, first approved treatment for certain forms for wet age related macular degeneration (AMD),combination studies with anti-VEGF (Lucentis) and steroid for [...]

Back to Top

Social Media Profiles

ADVERTISEMENT

BUSINESS NETWORKS

The New York Times logo CNN logo ABC logo CNBC logo